AXIS
轴
基本信息
- 批准号:8173586
- 负责人:
- 金额:$ 8.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Basic ScienceClinicalClinical ResearchCommunitiesComputer Retrieval of Information on Scientific Projects DatabaseConsultationsEnsureEnvironmentFundingGoalsGrantHealthHome environmentHousingInformation TechnologyInstitutesInstitutionLeadershipMedicineMinorityModelingNIH Program AnnouncementsOutcomePatientsPopulationPositioning AttributeResearchResearch PersonnelResearch TrainingResourcesScienceServicesSolutionsSourceStrategic PlanningTechnologyTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVisionbiomedical informaticscareer developmentcatalystcost effectiveexperiencehealth disparityimprovedinnovationinterdisciplinary collaborationnovelpatient oriented researchpublic health relevanceresponsetool
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
DESCRIPTION (provided by applicant): The vision of the Charles Drew University of Medicine and Science (CDU) Research Enterprise is to be a leading national resource for conducting clinical and translational research that produces high-quality, cost effective and culturally relevant solutions that improve health and wellness in minority and poor populations. By promoting strategies that create synergy in research teams and between investigators and the community, CDU will create novel best practice solutions to transform the health of underserved communities that can be used as innovative models throughout the nation and the world. CDU submits this application in response to the NIH Program Announcement (PAR-08-262) to implement the consolidation of the Comprehensive Center for Health Disparities (CCHD) and Clinical Research Center (CRC) into Accelerating Excellence in Science (AXIS). AXIS will be the catalyst to implement the CDU research strategic plan and will become the integrated "home" for clinical and translational research. AXIS will house experienced and dedicated leadership; a myriad of clinical and translational, community, training, and technology resources; and excellent research consultation services. As its cornerstone, AXIS wil have multiband interdisciplinary collaborations between CDU investigators and community partners. These team science activities will be supported by CDU biomedical informatics resources, and other innovative research tools and information technologies (detailed below) aligned in an integrated manner to create a vibrant center for clinical and translational science.
The overall purpose of AXIS is to better position CDU for conducting clinical and translational research, especially research that is focused on health disparities. The goals are to:
Goal 1: Transform the CDU research enterprise from traditional basic and clinical research domains into a highly integrated clinical and translational research environment by reorganizing research administration, centralizing and enhancing physical and intellectual resources, and promoting participation in the RCMI Translational Research Network (RTRN) and Clinical and Translational Science Institutes (CTSI).
Goal 2: Develop a unique model for community, multi-disciplinary, and/or multi-institutional partnerships that ensures that clinical and translational research yields high-quality, cost-effective health outcomes
Goal 3: Implement innovative translational research training and career development activities at CDU and in partnership with RTRN that recognize that the interdependence of basic science, clinical discovery, and patient-oriented research will accelerate improved patient outcomes.
PUBLIC HEALTH RELEVANCE (provided by the applicant): Not provided.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
描述(由申请人提供):查尔斯德鲁医学与科学大学 (CDU) 研究企业的愿景是成为开展临床和转化研究的领先国家资源,产生高质量、具有成本效益且与文化相关的解决方案,从而改善少数民族和贫困人口的健康和福祉。通过推广在研究团队以及研究人员和社区之间建立协同作用的战略,基民盟将创建新颖的最佳实践解决方案,以改变服务不足社区的健康状况,这些解决方案可以用作全国和世界各地的创新模式。 CDU 提交此申请是为了响应 NIH 计划公告 (PAR-08-262),以将健康差异综合中心 (CCHD) 和临床研究中心 (CRC) 合并为加速卓越科学 (AXIS)。 AXIS 将成为实施 CDU 研究战略计划的催化剂,并将成为临床和转化研究的综合“家”。 AXIS 将拥有经验丰富且敬业的领导层;大量的临床和转化、社区、培训和技术资源;以及卓越的研究咨询服务。作为其基石,AXIS 将在基民盟研究人员和社区合作伙伴之间进行多频段跨学科合作。这些团队科学活动将得到基民盟生物医学信息学资源以及其他创新研究工具和信息技术(详见下文)的支持,以综合方式结合起来,创建一个充满活力的临床和转化科学中心。
AXIS 的总体目标是让 CDU 更好地开展临床和转化研究,特别是关注健康差异的研究。目标是:
目标 1:通过重组研究管理、集中和增强物质和智力资源、促进参与 RCMI 转化研究网络(RTRN)和促进参与,将 CDU 研究企业从传统的基础和临床研究领域转变为高度集成的临床和转化研究环境。临床和转化科学研究所 (CTSI)。
目标 2:为社区、多学科和/或多机构合作伙伴关系开发独特的模式,确保临床和转化研究产生高质量、具有成本效益的健康结果
目标 3:在 CDU 并与 RTRN 合作实施创新的转化研究培训和职业发展活动,认识到基础科学、临床发现和以患者为导向的研究的相互依赖性将加速改善患者的治疗结果。
公共卫生相关性(由申请人提供):未提供。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith C Norris其他文献
Federal Regulations and Dialysis-Related Disparities.
联邦法规和透析相关的差异。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Jenny I. Shen;L. Golestaneh;Keith C Norris - 通讯作者:
Keith C Norris
Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
矿物质代谢趋势:肾脏早期评估计划 (KEEP) 和国家健康与营养检查调查 (NHANES) 1999-2004。
- DOI:
10.1053/j.ajkd.2007.12.018 - 发表时间:
2008-04-01 - 期刊:
- 影响因子:0
- 作者:
Joseph Vassalotti;Jaime Uribarri;S. Chen;Suying Li;Changchun Wang;A. J. Collins;Mona S. Calvo;A. Whaley;Peter A Mccullough;Keith C Norris - 通讯作者:
Keith C Norris
Adherence to the healthy eating index-2010 and alternative healthy eating index-2010 in relation to metabolic syndrome among African Americans in the Jackson heart study
杰克逊心脏研究中非裔美国人遵守 2010 年健康饮食指数和 2010 年替代健康饮食指数与代谢综合征的关系
- DOI:
10.1017/s1368980024000016 - 发表时间:
2024-02-16 - 期刊:
- 影响因子:3.2
- 作者:
N. Reeder;Jennifer C Reneker;Bettina M. Beech;Marino Bruce;Elizabeth Heitman;Keith C Norris;S. Talegawkar;Roland J Thorpe - 通讯作者:
Roland J Thorpe
K/DOQI clinical practice guidelines for chronic kidney disease
K/DOQI 慢性肾脏病临床实践指南
- DOI:
10.1093/ndt/14.suppl_6.31 - 发表时间:
2002-03-09 - 期刊:
- 影响因子:13.2
- 作者:
Andrew S. Levey;J. Coresh;K. Bolton;B. Culleton;Kathy Schiro Harvey;T. Ikizler;C. Johnson;A. Kausz;Paul L. Kimmel;J. Kusek;Adeera Levin;K. Minaker;Robert G. Nelson;Helmut G. Rennke;M. W. Steffes;Beth Witten;Ronald J. Hogg;S. Furth;K. Lemley;Ronald J. Portman;George J Schwartz;Joseph Lau;E. Balk;R. Perrone;T. Karim;Lara Rayan;Inas Al;P. Chew;B. C. Astor;De Vine;Garabed Eknoyan;Nathan W. Levin;S. Burrows‐Hudson;W. F. Keane;A. Kliger;D. Latos;D. Mapes;E. Oberley;K. Willis;G. Bailie;Gavin J. Becker;J. Burrowes;David N. Churchill;A. J. Collins;W. Couser;D. Dezeeuw;Alan J. Garber;T. Golper;F. Gotch;A. M. Gotto;Joel W. Greer;Richard H. Grimm;R. Hannah;Jaime Herrera Acosta;L. Hunsicker;M. Klag;Saulo Klahr;Caya Lewis;Edmund G. Lowrie;A. J. Matas;Sally McCulloch;Maureen A Michael;J. Nally;J. Newmann;Allen R. Nissenson;Keith C Norris;William F. Owen;Thakor G. Patel;Glenda Payne;R. Rivera;David A. Smith;Robert Alan Star;Theodore I. Steinman;F. Valderrábano;John Walls;J. Wauters;N. K. Wenger;Josephine P. Briggs - 通讯作者:
Josephine P. Briggs
Self-Reported Fatigue by the Chalder Fatigue Questionnaire and Mortality in Brazilian Hemodialysis Patients: The PROHEMO
Chalder 疲劳问卷自我报告的疲劳与巴西血液透析患者的死亡率:PROHEMO
- DOI:
10.1159/000533472 - 发表时间:
2023-12-02 - 期刊:
- 影响因子:2.5
- 作者:
G. Gutiérrez;Márcia Tereza Silva Martins;Fernanda Albuquerque da Silva;Marcelo Barreto Lopes;G. B. Lopes;Keith C Norris;Antonio Alberto Lopes - 通讯作者:
Antonio Alberto Lopes
Keith C Norris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keith C Norris', 18)}}的其他基金
NIDDK Short-Term Education Program for Underrepresented Persons at UCLA (UCLA STEP-UP)
NIDDK 加州大学洛杉矶分校弱势群体短期教育计划 (UCLA STEP-UP)
- 批准号:
9329857 - 财政年份:2017
- 资助金额:
$ 8.36万 - 项目类别:
UCLA Short-Term Research Experience to Unlock Potential (UCLA STEP-UP)
加州大学洛杉矶分校短期研究经验释放潜力(加州大学洛杉矶分校STEP-UP)
- 批准号:
10698024 - 财政年份:2017
- 资助金额:
$ 8.36万 - 项目类别:
UCLA Short-Term Research Experience to Unlock Potential (UCLA STEP-UP)
加州大学洛杉矶分校短期研究经验释放潜力(加州大学洛杉矶分校STEP-UP)
- 批准号:
10478536 - 财政年份:2017
- 资助金额:
$ 8.36万 - 项目类别:
NIH Diversity Program Consortium Coordination and Evaluation Center at UCLA
加州大学洛杉矶分校 (UCLA) NIH 多样性计划联盟协调与评估中心
- 批准号:
10438642 - 财政年份:2014
- 资助金额:
$ 8.36万 - 项目类别:
NIH Diversity Program Consortium Coordination and Evaluation Center at UCLA
加州大学洛杉矶分校 (UCLA) NIH 多样性计划联盟协调与评估中心
- 批准号:
9559770 - 财政年份:2014
- 资助金额:
$ 8.36万 - 项目类别:
相似国自然基金
基于脑灰-白质图卷积模型的SCD影像标记物提取及临床应用研究
- 批准号:62376150
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
甲硫氨酸代谢调控核仁功能促进高危型肝母细胞瘤恶性演进的机制及临床价值研究
- 批准号:82302617
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝细胞肝癌Glypican 3特异性定点标记免疫PET显像探针的创制与临床前研究
- 批准号:82302236
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肝癌门静脉癌栓临床需求导向的精氨酸基口服纳米药物的设计、合成及应用研究
- 批准号:22375033
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
B7-H3在分化型甲状腺癌颈淋巴结转移个体化治疗中的临床应用与分子研究
- 批准号:82373439
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 8.36万 - 项目类别:
Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience
生命早期压力诱发心血管疾病风险和恢复力的机制
- 批准号:
10555121 - 财政年份:2023
- 资助金额:
$ 8.36万 - 项目类别:
MT-125 for the Therapeutic Treatment of Glioblastoma
MT-125 用于胶质母细胞瘤的治疗
- 批准号:
10697940 - 财政年份:2023
- 资助金额:
$ 8.36万 - 项目类别: